Evidence-Based Imaging of Pancreatic Malignancies

Surgical Clinics of North America

Volumn 90, Issue 2, 2010, Pages 235-249

  Kinney, Timothy ^a  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

Computed tomography; Cystic neoplasms; Endoscopic ultrasound; Pancreatic cancer

Indexed keywords

CANCER DIAGNOSIS; CANCER STAGING; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EARLY CANCER; ENDOSCOPIC ECHOGRAPHY; EVIDENCE BASED MEDICINE; HUMAN; LIVER NODULE; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PANCREAS CYST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY; DIAGNOSTIC IMAGING; DILATATION, PATHOLOGIC; ENDOSONOGRAPHY; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77950789991     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2009.12.003     Document Type: Review

References (74)

1. Yeo C.J., Cameron J.L. Improving results of pancreaticoduodenectomy for pancreatic cancer. World J Surg 1999, 23:907-912.
2. Morrin M.M., Kruskal J.B., Raptopoulos V., et al. State-of-the-art ultrasonography is as accurate as helical computed tomography and computed tomographic angiography for detecting unresectable periampullary cancer. J Ultrasound Med 2001, 20:481-490.
3. Kinney T.P., Freeman M.L. Recent advances and novel methods in pancreatic imaging. Minerva Gastroenterol Dietol 2008, 54:85-95.
4. Brambs H.J., Claussen C.D. Pancreatic and ampullary carcinoma. Ultrasound, computed tomography, magnetic resonance imaging and angiography. Endoscopy 1993, 25:58-68.
5. Uomo G. Ultrasound elastography. A possible improvement into the paraphernalia of pancreatic imaging. JOP 2008, 9:666-667.
6. Hohl C., Schmidt T., Haage P., et al. Phase-inversion tissue harmonic imaging compared with conventional B-mode ultrasound in the evaluation of pancreatic lesions. Eur Radiol 2004, 14:1109-1117.
7. Balci N.C., Semelka R.C. Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma. Eur J Radiol 2001, 38:105-112.
8. Koito K., Namieno T., Nagakawa T., et al. Inflammatory pancreatic masses: differentiation from ductal carcinomas with contrast-enhanced sonography using carbon dioxide microbubbles. AJR Am J Roentgenol 1997, 169:1263-1267.
9. Lu D.S., Vedantham S., Krasny R.M., et al. Two-phase helical CT for pancreatic tumors: pancreatic versus hepatic phase enhancement of tumor, pancreas, and vascular structures. Radiology 1996, 199:697-701.
10. Wong J.C., Lu D.S. Staging of pancreatic adenocarcinoma by imaging studies. Clin Gastroenterol Hepatol 2008, 6:1301-1308.
11. Prokesch R.W., Chow L.C., Beaulieu C.F., et al. Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology 2002, 224:764-768.
12. Fulcher A.S., Turner M.A. MR pancreatography: a useful tool for evaluating pancreatic disorders. Radiographics 1999, 19:5-24. [discussion: 41-4; quiz: 148-9].
13. Legmann P., Vignaux O., Dousset B., et al. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol 1998, 170:1315-1322.
14. Bronstein Y.L., Loyer E.M., Kaur H., et al. Detection of small pancreatic tumors with multiphasic helical CT. AJR Am J Roentgenol 2004, 182:619-623.
15. Karmazanovsky G., Fedorov V., Kubyshkin V., et al. Pancreatic head cancer: accuracy of CT in determination of resectability. Abdom Imaging 2005, 30:488-500.
16. Lu D.S., Reber H.A., Krasny R.M., et al. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR Am J Roentgenol 1997, 168:1439-1443.
17. O'Malley M.E., Boland G.W., Wood B.J., et al. Adenocarcinoma of the head of the pancreas: determination of surgical unresectability with thin-section pancreatic-phase helical CT. AJR Am J Roentgenol 1999, 173:1513-1518.
18. Hough T.J., Raptopoulos V., Siewert B., et al. Teardrop superior mesenteric vein: CT sign for unresectable carcinoma of the pancreas. AJR Am J Roentgenol 1999, 173:1509-1512.
19. Li H., Zeng M.S., Zhou K.R., et al. Pancreatic adenocarcinoma: the different CT criteria for peripancreatic major arterial and venous invasion. J Comput Assist Tomogr 2005, 29:170-175.
20. Hommeyer S.C., Freeny P.C., Crabo L.G. Carcinoma of the head of the pancreas: evaluation of the pancreaticoduodenal veins with dynamic CT-potential for improved accuracy in staging. Radiology 1995, 196:233-238.
21. Roche C.J., Hughes M.L., Garvey C.J., et al. CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. AJR Am J Roentgenol 2003, 180:475-480.
22. Diehl S.J., Lehmann K.J., Sadick M., et al. Pancreatic cancer: value of dual-phase helical CT in assessing resectability. Radiology 1998, 206:373-378.
23. Walkey M.M., Friedman A.C., Sohotra P., et al. CT manifestations of peritoneal carcinomatosis. AJR Am J Roentgenol 1988, 150:1035-1041.
24. Schwartz L.H., Gandras E.J., Colangelo S.M., et al. Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 1999, 210:71-74.
25. Liu R.C., Traverso L.W. Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by computed tomography. Surg Endosc 2005, 19:638-642.
26. Hunt G.C., Faigel D.O. Assessment of EUS for diagnosing, staging, and determining resectability of pancreatic cancer: a review. Gastrointest Endosc 2002, 55:232-237.
27. Rosch T., Lightdale C.J., Botet J.F., et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 1992, 326:1721-1726.
28. Rosch T., Lorenz R., Braig C., et al. Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc 1991, 37:347-352.
29. Kinney T.P., Lai R., Freeman M.L. Endoscopic approach to acute pancreatitis. Rev Gastroenterol Disord 2006, 6:119-135.
30. Turrini O., Viret F., Moureau-Zabotto L., et al. Neoadjuvant 5 fluorouracil-cisplatin chemoradiation effect on survival in patients with resectable pancreatic head adenocarcinoma: a ten-year single institution experience. Oncology 2009, 76:413-419.
31. Satoi S., Yanagimoto H., Toyokawa H., et al. Surgical results after preoperative chemoradiation therapy for patients with pancreatic cancer. Pancreas 2009, 38:282-288.
32. Palazzo L., Roseau G., Gayet B., et al. Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography and CT scan. Endoscopy 1993, 25:143-150.
33. Gress F.G., Hawes R.H., Savides T.J., et al. Role of EUS in the preoperative staging of pancreatic cancer: a large single-center experience. Gastrointest Endosc 1999, 50:786-791.
34. Tio T.L., Tytgat G.N., Cikot R.J., et al. Ampullopancreatic carcinoma: preoperative TNM classification with endosonography. Radiology 1990, 175:455-461.
35. Grimm H., Maydeo A., Soehendra N. Endoluminal ultrasound for the diagnosis and staging of pancreatic cancer. Baillieres Clin Gastroenterol 1990, 4:869-888.
36. Muller M.F., Meyenberger C., Bertschinger P., et al. Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology 1994, 190:745-751.
37. Yasuda K., Mukai H., Nakajima M. Endoscopic ultrasonography diagnosis of pancreatic cancer. Gastrointest Endosc Clin N Am 1995, 5:699-712.
38. Brugge W.R., Lee M.J., Kelsey P.B., et al. The use of EUS to diagnose malignant portal venous system invasion by pancreatic cancer. Gastrointest Endosc 1996, 43:561-567.
39. Aslanian H., Salem R., Lee J., et al. EUS diagnosis of vascular invasion in pancreatic cancer: surgical and histologic correlates. Am J Gastroenterol 2005, 100:1381-1385.
40. Snady H., Bruckner H., Siegel J., et al. Endoscopic ultrasonographic criteria of vascular invasion by potentially resectable pancreatic tumors. Gastrointest Endosc 1994, 40:326-333.
41. DeWitt J., Devereaux B., Chriswell M., et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 2004, 141:753-763.
42. Bipat S., Phoa S.S., van Delden O.M., et al. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis. J Comput Assist Tomogr 2005, 29:438-445.
43. Kinney T.P., Punjabi G., Freeman M. Technology insight: applications of MRI for the evaluation of benign disease of the pancreas. Nat Clin Pract Gastroenterol Hepatol 2007, 4:148-159.
44. Ichikawa T., Sou H., Araki T., et al. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 2001, 221:107-116.
45. Johnson P.T., Outwater E.K. Pancreatic carcinoma versus chronic pancreatitis: dynamic MR imaging. Radiology 1999, 212:213-218.
46. Sica G.T., Ji H., Ros P.R. Computed tomography and magnetic resonance imaging of hepatic metastases. Clin Liver Dis 2002, 6:165-179. vii.
47. Frohlich A., Diederichs C.G., Staib L., et al. Detection of liver metastases from pancreatic cancer using FDG PET. J Nucl Med 1999, 40:250-255.
48. Orlando L.A., Kulasingam S.L., Matchar D.B. Meta-analysis: the detection of pancreatic malignancy with positron emission tomography. Aliment Pharmacol Ther 2004, 20:1063-1070.
49. Farnell M.B. Surgical management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas. J Gastrointest Surg 2008, 12:414-416.
50. Fasanella K.E., McGrath K. Cystic lesions and intraductal neoplasms of the pancreas. Best Pract Res Clin Gastroenterol 2009, 23:35-48.
51. Tanaka M., Chari S., Adsay V., et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006, 6:17-32.
52. Song S.J., Lee J.M., Kim Y.J., et al. Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: comparison of multirow-detector CT and MR imaging using ROC analysis. J Magn Reson Imaging 2007, 26:86-93.
53. Sahani D.V., Kadavigere R., Blake M., et al. Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations-correlation with MRCP. Radiology 2006, 238:560-569.
54. Mansour J.C., Schwartz L., Pandit-Taskar N., et al. The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas. J Gastrointest Surg 2006, 10:1354-1360.
55. Op de Beeck B., Spinhoven M., Corthouts B., et al. Management of cystic pancreatic masses. JBR-BTR 2007, 90:482-486.
56. Bassi C., Salvia R., Gumbs A.A., et al. The value of standard serum tumor markers in differentiating mucinous from serous cystic tumors of the pancreas: CEA, Ca 19-9, Ca 125, Ca 15-3. Langenbecks Arch Surg 2002, 387:281-285.
57. Fernandez-del Castillo C., Alsfasser G., Targarona J., et al. Serum CA19-9 in the management of cystic lesions of the pancreas. Pancreas 2006, 32:220.
58. Agostini S., Choux R., Payan M.J., et al. Mucinous pancreatic duct ectasia in the body of the pancreas. Radiology 1989, 170:815-816.
59. Farrell J.J., Brugge W.R. Intraductal papillary mucinous tumor of the pancreas. Gastrointest Endosc 2002, 55:701-714.
60. McDonald J.M., Williard W., Mais D., et al. The incidence of intraductal papillary mucinous tumors of the pancreas(1). Curr Surg 2000, 57:610-614.
61. Jang J.Y., Kim S.W., Ahn Y.J., et al. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery?. Ann Surg Oncol 2005, 12:124-132.
62. Manfredi R., Graziani R., Motton M., et al. Main pancreatic duct intraductal papillary mucinous neoplasms: accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis. Radiology 2009, 253:106-115.
63. Kubo H., Nakamura K., Itaba S., et al. Differential diagnosis of cystic tumors of the pancreas by endoscopic ultrasonography. Endoscopy 2009, 41:684-689.
64. Brugge W.R., Lewandrowski K., Lee-Lewandrowski E., et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004, 126:1330-1336.
65. Michaels P.J., Brachtel E.F., Bounds B.C., et al. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade. Cancer 2006, 108:163-173.
66. Levy M.J., Clain J.E. Evaluation and management of cystic pancreatic tumors: emphasis on the role of EUS FNA. Clin Gastroenterol Hepatol 2004, 2:639-653.
67. Kim S.Y., Lee J.M., Kim S.H., et al. Macrocystic neoplasms of the pancreas: CT differentiation of serous oligocystic adenoma from mucinous cystadenoma and intraductal papillary mucinous tumor. AJR Am J Roentgenol 2006, 187:1192-1198.
68. Sahani D.V., Kadavigere R., Saokar A., et al. Cystic pancreatic lesions: a simple imaging-based classification system for guiding management. Radiographics 2005, 25:1471-1484.
69. Allen P.J., D'Angelica M., Gonen M., et al. A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg 2006, 244:572-582.
70. Goh B.K., Tan Y.M., Chung Y.F., et al. A review of mucinous cystic neoplasms of the pancreas defined by ovarian-type stroma: clinicopathological features of 344 patients. World J Surg 2006, 30:2236-2245.
71. Warshaw A.L., Compton C.C., Lewandrowski K., et al. Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 67 patients. Ann Surg 1990, 212:432-443. [discussion: 444-5].
72. van der Waaij L.A., van Dullemen H.M., Porte R.J. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc 2005, 62:383-389.
73. Frossard J.L., Amouyal P., Amouyal G., et al. Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions. Am J Gastroenterol 2003, 98:1516-1524.
74. Song M.H., Lee S.K., Kim M.H., et al. EUS in the evaluation of pancreatic cystic lesions. Gastrointest Endosc 2003, 57:891-896.